Enhertu 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F9KY6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,115
Award facts
- Contract value 100% obligated
- $23,114.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,114.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 milligram vials of Enhertu, an oncology medication used in cancer treatment. The contract, awarded January 13, 2026, with an ultimate completion date of February 4, 2026, carries no set-aside designation and represents a competitive award to the prime contractor. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award IDC valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen's substantial IDC with the Defense Logistics Agency reflects the company's critical role as a major pharmaceutical distributor serving federal medical procurement needs across the Department of Defense, Defense Health Agency, and related military treatment facilities and veterans' healthcare programs. The firm fixed-price structure and delivery order format demonstrate the established pricing mechanisms under the larger IDC, which enables efficient fulfillment of essential pharmaceutical commodities across multiple therapeutic domains to support military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26F9KY6?
SPE2DR26F9KY6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F9KY6 worth?
The government has obligated $23,115 on SPE2DR26F9KY6.
Is contract SPE2DR26F9KY6 an order under another contract?
Yes. SPE2DR26F9KY6 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KY6 competed?
The extent of competition for SPE2DR26F9KY6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award